type 2 diabetic - Nursing Case Study
Pathophysiology
• Primary mechanism: Insulin resistance - The body's cells become less responsive to insulin, primarily due to lifestyle factors and genetic predisposition. This resistance prevents glucose from entering the cells efficiently, leading to elevated blood glucose levels.
• Secondary mechanism: Beta-cell dysfunction - Over time, insulin-producing beta cells in the pancreas become impaired or exhausted. They struggle to compensate for insulin resistance by producing enough insulin, further exacerbating hyperglycemia.
• Key complication: Hyperglycemia-induced damage - Persistent high blood glucose levels can damage blood vessels and nerves, leading to complications such as cardiovascular disease, neuropathy, retinopathy, and nephropathy, emphasizing the need for strict glycemic control in patients.
Patient Profile
Demographics:
56-year-old male, office administrator
History:
• Key past medical history: Type 2 diabetes diagnosed 8 years ago; hypertension; hyperlipidemia
• Current medications: Metformin 1000 mg twice daily; Lisinopril 20 mg daily; Atorvastatin 40 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increased fatigue and tingling in feet
• Key symptoms: Blurred vision; frequent urination; increased thirst; numbness in extremities
• Vital signs: Blood pressure 150/95 mmHg; heart rate 88 bpm; respiratory rate 18 breaths per minute; temperature 98.6°F; blood glucose 220 mg/dL
Section 1
During the initial assessment, further examination of the patient revealed several concerning findings. The patient's feet showed signs of peripheral neuropathy, with diminished sensation to light touch and pinprick in both feet, particularly in the toes. There was also evidence of decreased pedal pulses, indicating possible peripheral arterial disease. The patient's vision test revealed mild non-proliferative diabetic retinopathy, characterized by small retinal hemorrhages and microaneurysms. These findings correlate with the reported symptoms of blurred vision and tingling in the feet, suggesting that the patient's diabetes management may not be adequately controlling his blood glucose levels, leading to microvascular complications.
Laboratory results showed an HbA1c level of 9.2%, indicating poor long-term glycemic control. The lipid profile revealed elevated LDL cholesterol at 145 mg/dL, despite being on atorvastatin, and a triglyceride level of 220 mg/dL. Renal function tests indicated a slightly elevated creatinine level of 1.4 mg/dL, with a reduced estimated glomerular filtration rate (eGFR) of 58 mL/min/1.73m², raising concerns about the early stages of diabetic nephropathy. These findings highlight the need for an adjustment in the patient's medication regimen and a more aggressive approach to managing his diabetes and associated risk factors.
The healthcare team decided to initiate a comprehensive management plan, focusing on optimizing glycemic control and addressing cardiovascular risks. This included increasing the dose of metformin and considering the addition of a GLP-1 receptor agonist or SGLT2 inhibitor to improve glycemic control and provide cardiovascular protection. Lifestyle modifications, such as dietary changes, increased physical activity, and smoking cessation, were strongly emphasized. The patient was also referred to a podiatrist for regular foot care and an ophthalmologist to monitor and manage retinopathy. The new strategy aimed to prevent further progression of complications and improve overall health outcomes for the patient.
Section 2
Two months after the initial comprehensive management plan was implemented, the patient returned for a follow-up appointment. During this visit, the healthcare team assessed the patient's response to the interventions and gathered new diagnostic results. The patient reported increased adherence to the prescribed lifestyle modifications, including regular physical activity and adherence to a diet plan tailored to improve glycemic and lipid control. He also mentioned having quit smoking, which was a significant achievement given his history of tobacco use.
The patient's laboratory results showed some improvement: his HbA1c had decreased to 8.0%, indicating better glycemic control, though still above the target level. LDL cholesterol had reduced to 120 mg/dL, and triglycerides were now at 180 mg/dL, suggesting a positive response to the intensified lipid management strategy. However, renal function tests remained a concern, as the creatinine level had slightly increased to 1.5 mg/dL, and the eGFR had decreased to 54 mL/min/1.73m², suggesting a progression in diabetic nephropathy. Additionally, a new assessment of peripheral circulation revealed that while pedal pulses were still decreased, the patient had developed a small ulcer on the left great toe, raising concerns of potential complications from peripheral arterial disease.
These findings prompted the healthcare team to reconsider the patient’s medication regimen and reinforce education on foot care and monitoring for signs of infection. The addition of an SGLT2 inhibitor was considered not only to improve glycemic control but also to provide renal protective effects. The patient was counseled on the importance of maintaining optimal blood pressure control to slow the progression of nephropathy and was advised to continue regular follow-ups with the nephrologist. This progression in the patient's condition underscored the need for ongoing monitoring and adaptation of the management plan to address evolving complications effectively.
Section 3
Several weeks after the adjustment in his management plan, the patient returned for another follow-up appointment. During this visit, the healthcare team conducted a thorough assessment to evaluate the patient's response to the new interventions, particularly focusing on the introduction of the SGLT2 inhibitor and reinforced foot care education. The patient reported feeling more energized, attributing it to his new medication regimen and improved lifestyle habits. However, he expressed concerns about increased urination and persistent thirst, which he described as more pronounced than before.
Vital signs revealed a blood pressure of 138/88 mmHg, slightly elevated but within the acceptable range given his history. The patient's weight had decreased by 4 pounds since the last visit, suggesting some positive effect of lifestyle modifications and medication adjustments. The ulcer on the left great toe had reduced in size, showing mild signs of granulation, but there were new concerns about increased erythema and a slight malodor, indicating a possible infection. A detailed foot examination confirmed these findings, and an immediate culture swab was taken to identify any infectious organisms. The healthcare team noted that the pedal pulses remained weak, reinforcing the importance of aggressive peripheral arterial disease management.
Laboratory tests showed a further reduction in HbA1c to 7.6%, reflecting improved glycemic control, while creatinine levels remained stable at 1.5 mg/dL. However, the eGFR had decreased slightly to 52 mL/min/1.73m², indicating a need for vigilant renal monitoring. The team decided to initiate a course of antibiotics to address the potential infection in the ulcer and emphasized the critical importance of daily foot inspections and protective footwear. The patient was reminded of the necessity to maintain tight blood glucose and blood pressure control to prevent further nephropathy progression. This visit highlighted the ongoing complexities of managing type 2 diabetes with complications, necessitating dynamic and proactive adjustments to the treatment plan.
Section 4
A few weeks after the patient's last follow-up appointment, he presented again with concerns that warranted further evaluation. The patient reported feeling increasingly fatigued and noted a return of the persistent thirst he had experienced prior to his recent medication adjustments. This time, he also mentioned experiencing intermittent episodes of dizziness, particularly when standing up quickly.
During the examination, vital signs revealed a blood pressure of 142/90 mmHg, suggesting a slight upward trend that warranted closer attention. The patient's weight had remained stable since the previous visit, but a detailed foot examination raised new concerns. The ulcer on the left great toe showed signs of regression, with increased erythema and purulent discharge. Despite the ongoing antibiotic therapy, there was no significant improvement, prompting suspicion of an underlying osteomyelitis. Additionally, the foot examination noted diminished sensation, indicative of progressing peripheral neuropathy.
Laboratory results indicated a further decrease in eGFR to 48 mL/min/1.73m², emphasizing the need for renal protective strategies and possibly prompting a re-evaluation of current medications. A marked increase in CRP levels suggested an inflammatory process, consistent with the suspected infection. Given these findings, the healthcare team decided to refer the patient to a specialist for further evaluation of possible osteomyelitis and to consider advanced imaging. These developments underscored the need for continued vigilance in the management of his diabetes and its complications, emphasizing a multidisciplinary approach to optimize outcomes and prevent further deterioration.
Section 5
Following the referral to a specialist, the patient underwent advanced imaging, which confirmed the presence of osteomyelitis in the left great toe. This diagnosis necessitated a more aggressive approach to management, including the consideration of surgical intervention to prevent further bone damage and systemic spread of infection. Meanwhile, the patient's glycemic control came under scrutiny, as his HbA1c had risen to 8.5%, indicating suboptimal management of his diabetes. This prompted a review of his medication regimen and lifestyle factors, with discussions about the potential need for insulin therapy to achieve better glucose control.
In light of the confirmed osteomyelitis and the possibility of surgical intervention, the healthcare team prioritized optimizing the patient's cardiovascular and renal status. The nephrologist recommended initiating an angiotensin receptor blocker (ARB) to protect renal function, given the declining eGFR. Additionally, with the patient's blood pressure readings consistently in the hypertensive range, adjustments to his antihypertensive therapy were made, aiming to achieve a target blood pressure of less than 130/80 mmHg to mitigate further vascular complications.
The patient was also referred to a podiatrist for specialized care of the ulcerated foot and to a dietitian to reinforce dietary modifications that could support his overall health management. The interdisciplinary team emphasized the importance of adherence to treatment plans and close monitoring, highlighting the interconnectedness of his conditions and the role of comprehensive care in preventing new complications. These coordinated efforts aimed to stabilize his condition, improve quality of life, and avert the progression of diabetes-related complications.